- Home
- NAMS vs MLKN Comparison
NAMS vs MLKN Comparison
Compare NAMS & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- MLKN
- Stock Information
- Founded
- NAMS 2019
- MLKN 1905
- Country
- NAMS Netherlands
- MLKN United States
- Employees
- NAMS N/A
- MLKN N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- NAMS Health Care
- MLKN Consumer Discretionary
- Exchange
- NAMS Nasdaq
- MLKN Nasdaq
- Market Cap
- NAMS 1.7B
- MLKN 1.8B
- IPO Year
- NAMS N/A
- MLKN N/A
- Fundamental
- Price
- NAMS $25.50
- MLKN $22.55
- Analyst Decision
- NAMS Strong Buy
- MLKN
- Analyst Count
- NAMS 6
- MLKN 0
- Target Price
- NAMS $36.20
- MLKN N/A
- AVG Volume (30 Days)
- NAMS 1.4M
- MLKN 1.1M
- Earning Date
- NAMS 02-06-2025
- MLKN 12-18-2024
- Dividend Yield
- NAMS N/A
- MLKN 3.35%
- EPS Growth
- NAMS N/A
- MLKN 36.64
- EPS
- NAMS N/A
- MLKN 0.91
- Revenue
- NAMS $33,594,000.00
- MLKN $3,593,100,000.00
- Revenue This Year
- NAMS $129.49
- MLKN $4.04
- Revenue Next Year
- NAMS N/A
- MLKN $4.16
- P/E Ratio
- NAMS N/A
- MLKN $24.71
- Revenue Growth
- NAMS 78.77
- MLKN N/A
- 52 Week Low
- NAMS $10.50
- MLKN $20.89
- 52 Week High
- NAMS $27.29
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- NAMS 62.30
- MLKN 34.56
- Support Level
- NAMS $24.40
- MLKN $20.89
- Resistance Level
- NAMS $26.95
- MLKN $25.72
- Average True Range (ATR)
- NAMS 1.66
- MLKN 0.87
- MACD
- NAMS 0.41
- MLKN -0.29
- Stochastic Oscillator
- NAMS 81.51
- MLKN 35.05
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.